Estradiol 17-(β-D-Glucuronide) (sodium salt hydrate)

Estradiol 17-(β-D-Glucuronide) (sodium salt hydrate) （订货以CAS编码或英文名称为准）

Product Type|Biochemicals|Lipids|Sterol Lipids||Product Type|Biochemicals|Transporter & Exchanger Modulators||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Estrogens & Progestins||Research Area|Endocrinology & Metabolism|Reproductive Biology||Research Area|Toxicology & Xenobiotic Metabolism|Multidrug-Resistance Proteins

创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载

编号：PC55254

分子式：C13H18NOF

CAS号：389573-45-9

分子量：223.29

储存条件：-20

申请试用

货号	品牌	规格	纯度/含量	标准价	优惠价
PC55254-100mg	Medlife	100mg	≥95%	待询	登录后可见
PC55254-50mg	Medlife	EA	≥95%	¥5427.00	登录后可见
PC55254-10mg	Medlife	EA	≥95%	¥1885.00	登录后可见
PC55254-25mg	Medlife	EA	≥95%	¥3467.00	登录后可见
PC55254-5mg	Medlife	EA		¥989.00	登录后可见

中文名称：	(3R,4S)-4-(4-氟苯基)-3-羟甲基-1-甲基哌啶
中文别名：	((3R,4S)-4-(4-氟苯基)-1-甲基哌啶-3-基)甲醇;(3R,4S)-4-(4-氟苯基)-3-羟甲基-1-甲基哌啶
英文名称：	Estradiol 17-(β-D-Glucuronide) (sodium salt hydrate)
英文别名：	((3R,4S)-4-(4-Fluorophenyl)-1-methylpiperidin-3-yl)methanol;ent-Paroxol;(-)-trans-4-(4'-Fluorophenyl)-3-hydroxymethyl-N-methyl-piperidine;ent-Paroxo;[(3R,4S)-4-(4-Fluorophenyl)-1-methylpiperidinyl]methanol
CAS号：	389573-45-9
分子式：	C13H18NOF
分子量：	223.29
详细描述	Product Type\|Biochemicals\|Lipids\|Sterol Lipids\|\|Product Type\|Biochemicals\|Transporter & Exchanger Modulators\|\|Research Area\|Endocrinology & Metabolism\|Hormones & Receptors\|Estrogens & Progestins\|\|Research Area\|Endocrinology & Metabolism\|Reproductive Biology\|\|Research Area\|Toxicology & Xenobiotic Metabolism\|Multidrug-Resistance Proteins

搜索质检报告(COA)

相关产品

((3R,4R)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol compound with ((3S,4S)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methanol (1:1) hydrochloride

(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro- [1,1'-biphenyl]-4-yl)piperidine-1-carboxylate

(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- methoxyphenyl)piperidine-1-carboxylate

(3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine compound with (3S,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine(1:1) hydrochloride

(3S,3'S,4R,4'R)-diphenyl 3,3'-(oxybis(methylene))bis(4-(4- fluorophenyl)piperidine-1-carboxylate)

(3S,4R)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-phenyl piperidine-1-carboxylate

((cis)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methyl 4-methylbenzenesulfonate

(3S,3'S,4R,4'R)-3,3'-(oxybis(methylene))bis(4-(4-fluorophenyl)-1- methylpiperidine)

(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro-[1,1'- biphenyl]-3-yl)piperidine hydrochloride

(trans)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4'-fluoro-[1,1'-biphenyl]-4-yl)-1-methylpiperidine hydrochloride